Table of Contents Author Guidelines Submit a Manuscript
Table of Contents Alerts

To receive news and publication updates for International Journal of Endocrinology, enter your email address in the box below.

International Journal of Endocrinology
Volume 2017 (2017), Article ID 1547358, 6 pages
https://doi.org/10.1155/2017/1547358
Review Article

Screening for Cushing Syndrome at the Primary Care Level: What Every General Practitioner Must Know

Ernest Yorke,1 Yacoba Atiase,1 Josephine Akpalu,1 and Osei Sarfo-Kantanka2

1Endocrine & Diabetes Unit, Department of Medicine and Therapeutics, School of Medicine and Dentistry, College of Health Sciences, University of Ghana, Legon, Accra, Ghana
2Directorate of Medicine, Endocrine and Diabetes Unit, Komfo Anokye Teaching Hospital, Kumasi, Ghana

Correspondence should be addressed to Ernest Yorke; moc.oohay@muivolvap

Received 29 May 2017; Revised 4 July 2017; Accepted 11 July 2017; Published 27 July 2017

Academic Editor: Franco Veglio

Copyright © 2017 Ernest Yorke et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Boscaro, L. Barzon, F. Fallo, and N. Sonino, “Cushing’s syndrome,” Lancet (London, England), vol. 357, no. 9258, pp. 783–791, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. L. K. Nieman, B. M. K. Biller, J. W. Findling et al., “The diagnosis of Cushing’s syndrome: an endocrine society clinical practice guideline,” The Journal of Clinical Endocrinology & Metabolism, vol. 93, no. 5, pp. 1526–1540, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. Y. M. Olumide, A. O. Akinkugbe, D. Altraide et al., “Complications of chronic use of skin lightening cosmetics,” International Journal of Dermatology, vol. 47, no. 4, pp. 344–353, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. J. N. Rozen, E. Alseddeeqi, and J. Rivera, “Cosmetic agents causing endocrinopathy in an African immigrant,” Canadian Family Physician, vol. 58, no. 2, pp. 169–171, 2012. View at Google Scholar
  5. A. Lacroix, R. A. Feelders, C. A. Stratakis, and L. K. Nieman, “Cushing’s syndrome,” Lancet (London, England), vol. 386, no. 9996, pp. 913–927, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. US Census Bureau IDB, 2004, June 2017, http://www.cureresearch.com/c/cushings_syndrome/stats-country_printer.htm.
  7. S. T. Sharma, L. K. Nieman, and R. A. Feelders, “Cushing’s syndrome: epidemiology and developments in disease management,” Clinical Epidemiology, vol. 7, pp. 281–293, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Raff and T. Carroll, “Cushing’s syndrome: from physiological principles to diagnosis and clinical care,” The Journal of Physiology, vol. 593, no. 3, pp. 493–506, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. L. K. Nieman, “Cushing’s syndrome: update on signs, symptoms and biochemical screening,” European Journal of Endocrinology, vol. 173, no. 4, pp. M33–M38, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. D. L. Loriaux, “Diagnosis and differential diagnosis of Cushing’s syndrome,” New England Journal of Medicine, vol. 376, no. 15, pp. 1451–1459, 2017. View at Publisher · View at Google Scholar
  11. A. J. Cameron, J. E. Shaw, and P. Z. Zimmet, “The metabolic syndrome: prevalence in worldwide populations,” Endocrinology and Metabolism Clinics of North America, vol. 33, no. 2, pp. 351–375, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. I. Bourdeau, C. Bard, B. Noël et al., “Loss of brain volume in endogenous Cushing’s syndrome and its reversibility after correction of hypercortisolism,” The Journal of Clinical Endocrinology & Metabolism, vol. 87, no. 5, pp. 1949–1954, 2002. View at Publisher · View at Google Scholar
  13. A. R. Hermus, A. G. Smals, L. M. Swinkels et al., “Bone mineral density and bone turnover before and after surgical cure of Cushing’s syndrome,” The Journal of Clinical Endocrinology & Metabolism, vol. 80, no. 10, pp. 2859–2865, 1995. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Sonino, F. Fallo, and G. A. Fava, “Psychosomatic aspects of Cushing’s syndrome,” Reviews in Endocrine & Metabolic Disorders, vol. 11, no. 2, pp. 95–104, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. L. Guignat and J. Bertherat, “The diagnosis of Cushing’s syndrome: an Endocrine Society Clinical Practice Guideline: commentary from a European perspective,” European Journal of Endocrinology, vol. 163, no. 1, pp. 9–13, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. V. Bansal, N. E. Asmar, W. R. Selman, and B. M. Arafah, “Pitfalls in the diagnosis and management of Cushing’s syndrome,” Neurosurgical Focus, vol. 38, no. 2, article E4, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Raff, R. J. Auchus, J. W. Findling, and L. K. Nieman, “Urine free cortisol in the diagnosis of Cushing’s syndrome: is it worth doing and, if so, how?” The Journal of Clinical Endocrinology & Metabolism, vol. 100, no. 2, pp. 395–397, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Vogeser and K. G. Parhofer, “Liquid chromatography tandem-mass spectrometry (LC-MS/MS)-technique and applications in endocrinology,” Experimental and Clinical Endocrinology & Diabetes, vol. 115, no. 09, pp. 559–570, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. F. Ceccato, M. Barbot, M. Zilio et al., “Screening tests for Cushing’s syndrome: urinary free cortisol role measured by LC-MS/MS,” The Journal of Clinical Endocrinology & Metabolism, vol. 100, no. 10, pp. 3856–3861, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. Q. Zhang, J. Dou, W. Gu, G. Yang, and J. Lu, “Reassessing the reliability of the salivary cortisol assay for the diagnosis of Cushing syndrome,” Journal of International Medical Research, vol. 41, no. 5, pp. 1387–1394, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. T. C. Friedman, “An update on the overnight dexamethasone suppression test for the diagnosis of Cushing’s syndrome: limitations in patients with mild and/or episodic hypercortisolism,” Experimental and Clinical Endocrinology & Diabetes, vol. 114, no. 7, pp. 356–360, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. P. C. Hindmarsh and C. G. D. Brook, “Single dose dexamethasone suppression test in children: dose relationship to body size,” Clinical Endocrinology, vol. 23, no. 1, pp. 67–70, 1985. View at Google Scholar
  23. M. Sahin, L. Kebapcilar, A. Taslipinar et al., “Comparison of 1 mg and 2 mg overnight dexamethasone suppression tests for the screening of Cushing’s syndrome in obese patients,” Internal Medicine, vol. 48, no. 1, pp. 33–39, 2009. View at Google Scholar
  24. T. Carroll, H. Raff, and J. Findling, “Late-night salivary cortisol for the diagnosis of Cushing syndrome: a meta-analysis,” Endocrine Practice, vol. 15, no. 4, pp. 335–342, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. P. Putignano, P. Toja, A. Dubini, F. P. Giraldi, S. M. Corsello, and F. Cavagnini, “Midnight salivary cortisol versus urinary free and midnight serum cortisol as screening tests for Cushing’s syndrome,” The Journal of Clinical Endocrinology & Metabolism, vol. 88, no. 9, pp. 4153–4157, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. J. D. Carmichael, G. Zada, and W. R. Selman, “Editorial: making the diagnosis of cyclic Cushing’s syndrome: a position statement from the topic editors,” Neurosurgical Focus, vol. 38, no. 2, article E8, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. P. C. L. Elias, E. Z. Martinez, B. F. C. Barone, L. M. Mermejo, M. Castro, and A. C. Moreira, “Late-night salivary cortisol has a better performance than urinary free cortisol in the diagnosis of Cushing’s syndrome,” The Journal of Clinical Endocrinology & Metabolism, vol. 99, no. 6, pp. 2045–2051, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. E. Valassi, H. Franz, T. Brue et al., “Diagnostic tests for Cushing’s syndrome differ from published guidelines: data from ERCUSYN,” European Journal of Endocrinology, vol. 176, no. 5, pp. 613–624, 2017. View at Publisher · View at Google Scholar
  29. J. A. Yanovski, G. B. Cutler, G. P. Chrousos, and L. K. Nieman, “Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration: a new test to distinguish Cushing’s syndrome from pseudo-Cushing’s states,” JAMA, vol. 269, no. 17, pp. 2232–2238, 1993. View at Google Scholar
  30. J. Newell-Price, P. Trainer, L. Perry, J. Wass, A. Grossman, and M. Besser, “A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing’s syndrome,” Clinical Endocrinology, vol. 43, no. 5, pp. 545–550, 1995. View at Google Scholar
  31. R. Gilbert and E. M. Lim, “The diagnosis of Cushing’s syndrome: an endocrine society clinical practice guideline,” Clinical Biochemist Reviews, vol. 29, no. 3, pp. 103–106, 2008. View at Google Scholar
  32. B. R. Carr, C. R. Parker, J. D. Madden, P. C. MacDonald, and J. C. Porter, “Maternal plasma adrenocorticotropin and cortisol relationships throughout human pregnancy,” American Journal of Obstetrics and Gynecology, vol. 139, no. 4, pp. 416–422, 1981. View at Google Scholar